Back to Trials
NCT05776316NARecruiting

Harm Reduction Services

NYU Langone Health

Start Date

11/25/2024

Completion Date

3/28/2028

Summary

The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * at least 18 years of age * self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria * English or Spanish speaking * able to provide informed consent. Exclusion Criteria: * inability to provide informed consent or participate in the study procedures as proposed in the consent * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder) * an unwillingness to be randomized. * are prisoners

Interventions

BEHAVIORAL

Integrated Harm Reduction Intervention (IHRI)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Drug UseSubstance AbuseMental Illness

Locations

Yale University

New Haven, Connecticut 06520

United States

NYU Langone Health

New York, New York 10016

United States

Nathan Kline Institute

Orangeburg, New York 10962

United States